Status:
UNKNOWN
Postoperative Diet With Hyperproteic Supplement Versus a Supplement With Imunonutrients, in Colorectal Cancer Surgery
Lead Sponsor:
Hospital General Universitario Reina Sofía de Murcia
Conditions:
Nutrition Related Neoplasm/Cancer
Colorectal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study is a randomized, multicentric, double-blind, controlled with active comparator, parallel groups trial, to demonstrate the non-inferiority in efficacy and therapeutic safety of the postoperat...
Detailed Description
The study is a randomized, multicentric, double-blind, controlled with active comparator, parallel groups trial, to demonstrate the non-inferiority in efficacy and therapeutic safety of the postoperat...
Eligibility Criteria
Inclusion
- Being over 18 years.
- Clinical diagnosis (pre-surgical) of colorectal carcinoma stage I-III, classification TNM, 6th edition.
- Normal nutritional status or without any intervention on their nutritional status, with a score lower than 2 according to the Malnutrition Screening Tool (MST) scale.
- Accepts participating in the Multimodal Rehabilitation Clinical Pathway in Patients submitted to a Bowel, Colorectal Anastomosis of HGURS.
- Accept signing informed consent.
Exclusion
- Age under 18.
- Clinical diagnosis (pre-surgical) of colorectal carcinoma stage IV.
- ASA Staging (American Society of Anesthesiologists) IV
- Chronic renal failure in dialysis.
- Pregnant.
- Difficulty or inability to understand the purpose of the study and controls.
- Refuses to sign informed consent.
Key Trial Info
Start Date :
June 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 20 2020
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT04059731
Start Date
June 20 2019
End Date
June 20 2020
Last Update
August 16 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General Universitario Reina Sofía
Murcia, Spain, 30003